Detail akcie Xtant Medical Rg online

Business Summary: Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, and Interbody products.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Xtant Medical Holdings Inc revenues increased 18% to $101.6M. Net income totaled $4.9M vs. loss of $13.3M. Revenues reflect Orthobiologics segment increase of 13% to $54.6M, United States segment increase of 21% to $92.6M, Rest of World segment remaining flat at $9M. Net Income reflects Sales and marketing decrease of 8% to $34.6M (expense), General and administrative decrease of 4% to $22.1M (expense).